Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skeletal Muscle Area-based Paclitaxel Infusion in Cancer
NCT05183126Phase 4Recruiting
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Mar 2022
- Primary completion
- Nov 2026
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of Paclitaxel Micelles for Injection in breast cancer, gastric cancer (GC), esophageal cancer, sponsored by University of Michigan Rogel Cancer Center. Started Mar 2022; status: recruiting.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
breast cancergastric cancer (GC)esophageal cancer
Beyond the preview
Go deeper on NCT05183126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05183126.